Company intelligence / Profile preview

Calyan Technologies

Saint Paul, Minnesota, USA

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Calyan Technologies is developing an injectable, leadless wireless single chamber VVIR pacemaker for the treatment of bradycardia. The technology is currently approved only for clinical study use in India and has not yet reached commercial markets. The company’s platform allows potential rapid expansion into related areas such as dual-chamber pacing and implantable defibrillation therapy.

Therapeutic areas: Cardiovascular
Modalities: DeviceImplantable medical deviceWireless pacemaker system
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Calyan Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calyan Technologies.

Explore the full profile